Medical Devices Acquisitions in California

GCM, a precision manufacturer backed by Avista Healthcare Partners, has acquired Kettmann Machining, a San Jose-based maker of precision-machined plastic and metal parts for the MedTech industry. The add-on expands GCM's capacity with a modern 40,000 sq. ft. facility and deepens its high-precision manufacturing capabilities to support next-generation medical device OEMs.

Symmetry Laser has completed the acquisition of ArcRev, adding specialized laser-cutting expertise and production capacity to expand its precision manufacturing platform for the medical device industry. The deal strengthens Symmetry Laser's ability to support customers from rapid prototyping through high-volume production, preserves ArcRev's team and operations, and was advised by Covington Partners; financial terms were not disclosed.

Laborie Medical Technologies has completed the acquisition of the JADA® System and the team behind it from Organon in a transaction announced in late January 2026. The deal — part of Organon’s divestiture program (previously disclosed as up to $465 million) — brings more than 90 employees and an FDA-cleared device for rapid control of postpartum hemorrhage into Laborie’s obstetrics portfolio to expand the company’s maternal health capabilities.

Strive, Inc. (Nasdaq: ASST) announced the completion of its acquisition of Semler Scientific, Inc. As a result of the transaction, Strive holds approximately 12,797.9 bitcoin and has appointed Avik Roy as Chief Strategy Officer to help monetize Semler's operating business and expand its early disease detection product efforts.

On January 12, 2026, Boston Scientific acquired Valencia Technologies, the developer of the eCoin System — a coin-sized subcutaneous neuromodulation device for hypertension. The acquisition expands Boston Scientific's neuromodulation and cardiovascular device portfolio by adding a novel, minimally invasive therapy and provides Valencia access to Boston Scientific's regulatory, distribution, and commercialization resources.

KVP International has acquired SafePath Laboratories and IVD Research (together SafePath-IVD), a Carlsbad, California–based diagnostics manufacturer and CDMO with FDA, ISO 13485 and USDA licenses. KVP will use SafePath-IVD as its dedicated research, development and manufacturing partner to expand veterinary point-of-care diagnostics while supporting SafePath-IVD's continued growth in human diagnostics and CDMO services.

Prescott's Med has acquired Tenacore, a Costa Mesa, California-based provider of depot-based medical device repair, parts, and technical support. The deal expands Prescott's Med's nationwide depot footprint and service capabilities for hospitals, ISOs, and in-house biomedical departments.

ARCHIMED Diagnostics (ARCHIMED’s diagnostics team) has acquired a 60% stake in Fremont-based ARK Diagnostics from Soulbrain Holdings in a transaction valuing ARK at $428 million. Soulbrain retains and reinvests in a 40% stake and the deal includes a joint-venture agreement to accelerate ARK’s product development and global expansion.

B. Braun SE has completed a full acquisition of True Digital Surgery (TDS), bringing the Goleta-based developer of robotic-assisted 3D surgical microscopy fully into its Aesculap surgical division. The deal integrates TDS's team and IP to accelerate development and global rollout of the AEOS digital exoscope platform for neurosurgery, spine and ENT procedures; financial terms were not disclosed.

MegaGen Implant, a South Korea–based dental implant manufacturer, has acquired BIOLASE, the Foothill Ranch, California–based leader in dental laser technology. The deal brings BIOLASE under MegaGen's ownership with MegaGen founder Dr. Kwang Bum Park named BIOLASE's new CEO and signals renewed investment, operational integration, and capability expansion of BIOLASE's product and service offerings.

Medical Manufacturing Technologies (MMT), a portfolio company of Arcline Investment Management, has acquired Innova Design, Inc., a pioneer in laser bonding equipment for catheter and interventional medical device manufacturing. The acquisition expands MMT’s bonding technology suite—adding Innova’s laser bonder platforms and related capabilities—to better serve medical device OEMs globally.

ZYTOMICS, a Berlin-based cancer diagnostics company, has acquired Applied Spectral Imaging (ASI), a leader in digital imaging solutions for pathology and cytogenetics laboratories. The acquisition will integrate ASI's imaging platforms and analysis software with ZYTOMICS' reagents, automation and analytics to create an end-to-end offering for diagnostic labs and accelerate product and technology innovation.

EQT Life Sciences, together with the LSP 7 fund and EQT Health Economics strategy, co-led a $56 million Series D financing in Neuros Medical to support U.S. commercialization of the Altius direct electrical nerve stimulation system for chronic post-amputation pain. Proceeds will fund scaling of commercial operations to expand access to the FDA‑approved, non‑opioid treatment for adult amputees.

TEAM Technologies (TEAM Tech), a PE‑backed contract manufacturer, has acquired Duke Empirical, Inc., a Morgan Hill, California designer and manufacturer of advanced catheters and minimally invasive delivery systems. The transaction expands TEAM Tech’s capabilities in catheter design, precision extrusion and high‑precision assembly, strengthening its offering for interventional cardiology, neurovascular and other minimally invasive device markets.

TEAM Technologies, a portfolio company of Arlington Capital Partners, has acquired Duke Empirical, a Morgan Hill, California-based designer and manufacturer of advanced catheters and minimally invasive delivery systems. The add-on expands TEAM Tech's end-to-end medical device manufacturing capabilities — including polymer extrusion and interventional cardiovascular device production — to better serve medical device OEMs and accelerate manufacturing at scale.

Addtronics, a consolidator of niche automation technology providers and a portfolio company of Kaho Partners, has acquired DAC International, a Carpinteria, California-based manufacturer of ultra‑precision equipment for contact lens and intraocular lens production. Route 2 Capital Partners provided subordinated debt and an equity investment to support the transaction, which strengthens Addtronics' medical device/ophthalmic automation capabilities.

Waters Corporation has acquired Halo Labs, a venture-backed developer of the Aura imaging platform for subvisible and visible particle analysis used in cell, gene and protein therapy development and QA/QC. The deal brings Halo Labs' high-throughput, low-volume particle analysis technology into Waters' Wyatt Technology portfolio to expand Waters' analytical and bioprocessing testing capabilities for large-molecule therapies.

Eargo and hearX (maker of Lexie Hearing) have completed a merger to form LXE Hearing, combining their consumer hearing-aid brands and technology platforms. The transaction is backed by an additional $100 million investment from Patient Square Capital to support growth, product integration and expanded access in the OTC hearing-aid market.

Creative Science, a CIMA Animal Health company (portfolio company of Incline Equity Partners), has acquired Infiniti Medical LLC and its subsidiary Orthomed UK Ltd. The deal adds veterinary interventional radiology, cardiology, soft-tissue surgery and orthopedic products and training capabilities to Creative Science's animal health platform to accelerate product innovation, manufacturing scale and educational programs for veterinarians.

Plastiflex Group, the IK Partners-backed manufacturer of tubing systems, acquired two healthcare-focused businesses — Smooth-Bor Plastics (Laguna Hills, CA) and TIK d.o.o. (Kobarid, Slovenia) — as add-on acquisitions to strengthen its respiratory care and catheter manufacturing capabilities. The transactions expand Plastiflex’s product portfolio and global manufacturing footprint (bringing the Group to 12 sites) and support its buy-and-build growth plan toward ~€200m sales and ~€50m EBITDA in 2025.

Arterex has acquired Adroit USA Inc., a vertically integrated medical device contract manufacturer with facilities in Bangalore, India and a U.S. engineering lab in Milpitas, California. The deal adds over 650 employees and expanded injection molding, precision metal fabrication and assembly capabilities, strengthening Arterex’s global manufacturing footprint and offering an alternative production source to China.

Aspen Medical Products, the Irvine-based spinal orthopedics manufacturer, has acquired Advanced Orthopaedics, a manufacturer and supplier of bracing solutions and orthopedic soft goods. The acquisition expands Aspen’s product portfolio into the bracing and supports market and is intended to strengthen service to distributors, hospitals, DME suppliers and retail partners while enhancing Aspen’s global reach.

Astorg has signed a definitive agreement to acquire FUJIFILM Irvine Scientific's Medical Media Business (Irvine Scientific MBU) from FUJIFILM Irvine Scientific, adding culture and vitrification media products to its recently combined assisted reproductive technology (ART) platform created from Hamilton Thorne and Cook Medical's Reproductive Health business. The deal is an add-on designed to create a global ART MedTech leader by expanding product capabilities for fertility clinics and IVF laboratories; financial terms were not disclosed.

Hologic has completed the acquisition of Gynesonics for approximately $350 million. The purchase adds the Sonata System — a minimally invasive intrauterine ultrasound-guided radiofrequency ablation platform for treating uterine fibroids — to Hologic's portfolio, expanding its capabilities in women's health surgical solutions.

Bausch + Lomb Corporation (through an affiliate) has acquired Elios Vision, Inc., developer of the ELIOS excimer-laser MIGS system, expanding Bausch + Lomb's glaucoma surgical capabilities and complementing its cataract surgery portfolio. The ELIOS technology, currently CE marked and marketed in the EU, is undergoing pursuit of FDA approval and will be commercialized more broadly through Bausch + Lomb's global cataract surgery channels.

Lafayette Instrument, a Branford Castle Partners portfolio company, has acquired the ALZET Osmotic Pumps business from DURECT Corporation as an add-on to expand Lafayette’s life-science instrumentation offering. The acquisition strengthens Lafayette’s preclinical dosing product line and represents the fourth bolt-on for the company since Branford Castle’s 2021 investment; the deal includes senior and mezzanine debt financing.

Boston Scientific Corporation agreed to and completed the acquisition of Axonics, Inc., a publicly traded medical technology company focused on sacral neuromodulation and urology devices, for $71 per share (approximately $3.7 billion equity value). The deal expands Boston Scientific’s urology portfolio by adding Axonics’ SNM therapy products and related technologies, expected to be accretive to its Urology business over time.

MDC (Medical Device Components), a Montagu-backed precision medical components platform, has acquired Lighteum, a nitinol-based medical component manufacturer. The add-on acquisition, which closed on November 8, 2024, expands MDC's nitinol processing and rapid-prototyping capabilities and extends manufacturing footprint in San Diego, Mexicali and Australia.

Savillex, a portfolio company of Thompson Street Capital Partners (TSCP), has acquired Optimum Processing, Inc., a San Rafael-based manufacturer of custom single-use bioprocessing bags and systems. The acquisition expands Savillex's product portfolio and presence in the San Francisco Bay Area to provide end-to-end container and containment solutions for pharmaceutical, biopharmaceutical and contract manufacturing customers.

Viant (Viant Medical) has acquired Fremont, California–based Knightsbridge Plastics to add precision micro-molding and injection-molded component capabilities to its medical device design and manufacturing services. The deal expands Viant’s global centers of excellence and strengthens its end-to-end manufacturing capabilities for next‑generation medical devices and advanced drug‑delivery systems.

StarFish Medical, a North American medical device development firm, has acquired Omnica Corporation, a 40-year-old medical device design and engineering company based in Irvine, California. The acquisition expands StarFish's West Coast footprint and adds Omnica's prototyping, engineering and regulatory capabilities while retaining Omnica's existing team.

Sunrise Medical, the global assistive mobility manufacturer headquartered in Malsch, Germany, has acquired Nuprodx Inc., a Livermore, California–based maker of patented bathroom mobility and shower/tub slider systems. The deal expands Sunrise Medical’s product portfolio in bathroom mobility solutions and gives Nuprodx access to Sunrise’s larger North American and global distribution network.

Bioventus has signed a definitive agreement to sell the Advanced Rehabilitation business of its subsidiary Bioness to private equity firm Accelmed Partners for total cash consideration of $45 million (including up to $20 million in earn-outs). The divestiture reduces Bioventus' annual revenue by about $50 million and allows Bioventus to focus on its core business while Accelmed plans to invest in and expand the Bioness rehabilitation product line.

Novo Holdings led a $50 million investment in Route 92 Medical as a Series F extension, joining returning investors U.S. Venture Partners, Norwest Venture Partners, InnovaHealth Partners, and The Vertical Group. The financing will accelerate global commercialization of Route 92's neurovascular intervention product portfolio and support regulatory authorizations in new geographies; Novo Holdings' Noel Jee will join Route 92's board.

BD (Becton, Dickinson and Company) completed the acquisition of Edwards Lifesciences' Critical Care product group and has renamed the business BD Advanced Patient Monitoring, based in Irvine, California. The deal expands BD's smart connected care portfolio with advanced monitoring technologies and AI-enabled clinical decision tools, and aligns the new unit within BD's Medical segment to enable integration with BD's infusion platforms and future closed-loop monitoring innovations.

Stryker has entered into a definitive agreement to acquire Vertos Medical Inc., a privately held company that develops the minimally invasive Mild® procedure for treating lumbar spinal stenosis. The acquisition expands Stryker’s interventional pain management and minimally invasive treatment portfolio and extends its reach into ambulatory surgery centers; the transaction remains subject to customary closing conditions.

Bausch + Lomb Corporation announced that an affiliate has acquired Trukera Medical (formerly TearLab) from private equity owner AccelMed Partners and other shareholders. The tuck‑in acquisition brings the ScoutPro point‑of‑care tear osmolarity diagnostic into Bausch + Lomb’s surgical portfolio to strengthen preoperative dry eye assessment and expand its U.S. surgical presence.

Boston Scientific Corporation agreed to acquire Silk Road Medical, Inc. for $27.50 per share in an all-cash transaction valuing Silk Road's equity at approximately $1.26 billion. The acquisition brings Silk Road's TransCarotid Artery Revascularization (TCAR) platform into Boston Scientific's vascular portfolio to expand treatment options for carotid artery disease and strengthen the company's vascular technology offerings.

Click Therapeutics has acquired the assets of Better Therapeutics, Inc., including the FDA-authorized digital therapeutic AspyreRx (BT-001) and development candidates BT-002, BT-003 and BT-004. Click will integrate Better’s intellectual property into its AI-enabled platform to accelerate development of obesity and cardiometabolic digital therapeutics, optimizing programs for use alongside anti-obesity and diabetes medications.

Johnson & Johnson will acquire Shockwave Medical for $335.00 per share in an all-cash transaction valued at approximately $13.1 billion including cash acquired. The deal adds Shockwave’s intravascular lithotripsy (IVL) technology to Johnson & Johnson MedTech, expanding J&J’s cardiovascular intervention portfolio and accelerating growth in high‑growth CAD and PAD markets.

Henry Schein, Inc. completed the acquisition of a majority interest in TriMed, Inc., a Santa Clarita, California–based developer of orthopedic implants and solutions for lower and upper extremities. TriMed reported approximately $52 million in 2023 net sales; the TriMed founders will remain with the business and financial terms were not disclosed. Henry Schein said the deal will broaden its surgical product offering to IDNs and ASCs and is expected to be neutral to 2024 non-GAAP EPS and accretive thereafter.

Integra LifeSciences Holdings Corporation has completed its acquisition of Acclarent, Inc., a maker of ear, nose and throat (ENT) surgical devices. The transaction expands Integra’s product portfolio into the ENT device segment, adding approximately $1 billion to the company’s total addressable market and providing scale through Acclarent’s commercial and R&D capabilities.

Montagu, a London-based private equity firm, has agreed to acquire Johnson Matthey’s carved-out Medical Device Components (MDC) business to create a standalone precision-components platform supporting minimally invasive medical devices. The transaction (reported at approximately US$700 million) will leave MDC led by its existing management and is subject to customary regulatory approvals.

FotoFinder Systems GmbH, a portfolio company of EMZ Partners, has acquired DermLite Holdco I, Inc. from DW Healthcare Partners' Founders Fund. The deal combines DermLite’s California-based dermatoscope and imaging hardware business with FotoFinder’s global skin imaging platform to create a stronger global player in digital dermoscopy and early skin cancer detection.

Belgium-based IBA (Ion Beam Applications S.A.) has signed an agreement to acquire all assets of Radcal Corporation, a California-based leader in diagnostic X‑ray measurement and dosimetry. The acquisition strengthens IBA's Medical Imaging Quality Assurance offering and expands its presence in the US; Radcal generated approximately USD 6 million in revenue in 2023 and employs about 35 people.

Nordic Pharma Group B.V., through its U.S. subsidiary Amring Pharmaceuticals Inc., has completed the acquisition of Visant Medical, Inc., bringing the FDA-cleared hyaluronic acid canalicular occlusive device LACRIFILL into the Nordic Pharma portfolio. Nordic will launch and commercialize LACRIFILL in the United States, expanding its ophthalmology product offering and enabling future global regulatory filings.

Johnson & Johnson MedTech has completed the acquisition of Laminar, Inc., a privately held medical device developer focused on eliminating the left atrial appendage (LAA) in patients with non‑valvular atrial fibrillation, for $400 million upfront plus potential clinical and regulatory milestone payments. Laminar will join Johnson & Johnson MedTech’s Biosense Webster business to expand the company’s electrophysiology and interventional cardiology portfolio and accelerate development and commercialization of Laminar’s rotational LAA elimination technology.

Probo Medical, a provider of diagnostic imaging equipment and services backed by Avista Capital Partners, has acquired Davis Medical Electronics, Inc., a long-standing supplier of cardiology equipment and supplies founded in 1983. The deal expands Probo's cardiology-focused offering and strengthens its footprint in the western United States; financial terms were not disclosed.

Aterian Investment Partners closed Aterian Opportunities II, LP, a ~$460 million single-asset continuation vehicle to purchase Vander-Bend Manufacturing from Aterian Investment Partners II (Fund II). The transaction provides approximately $90 million of incremental growth equity to Vander-Bend and is anchored by investors including J.P. Morgan Global Alternatives, Hollyport Capital and Blackstone Strategic Partners; Aterian management and certain Fund II LPs rolled meaningful equity.

Hamburg-based 3B Scientific has acquired Wallcur LLC, a San Diego-based provider of medical simulation products and educational materials. The acquisition expands 3B Scientific's medical simulation and anatomical-model product offering and keeps Wallcur operating under its existing brand with leadership continuity.